Antibody-based therapeutic approaches have been enthusiastically pursued over many years with the prime example of successful cases being ant-programmed cell death protein 1 (PD1) and anti- checkpoints T-lymphocyte-associated protein 4 (CTLA-4) cancer immune-therapies38. The gene discussed is PDCD1; the disease is cancer.